NCT02529748

Brief Summary

Dermal transfer efficiency has been defined as the amount of material that moves from one surface to another following contact. The investigators propose to measure dermal transfer efficiency for the following pathways: (1) object to skin, (2) skin to skin, (3) skin to mouth, (4) clothing to skin, (5) gloves to skin, and (6) air to skin. First, the quantitative dermal transfer will be measured for the two selected test substances (lead, Tinopal) for each of these six pathways. The relative quantities of dermal transfer will also then be compared between the different transfer pathways (e.g., is skin to skin transfer greater or less than clothing to skin transfer?). And second, the pattern of transfer will be characterized semi-quantitatively (e.g., does dermal transfer occur consistently and evenly to the skin from different reservoirs?).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 11, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 20, 2015

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

August 15, 2019

Status Verified

August 1, 2019

Enrollment Period

4 years

First QC Date

August 11, 2015

Last Update Submit

August 13, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quantitative mass of test substance per area of skin as measured through surface sampling

    Participants will handle or touch the approved test substances or an intermediate transfer material such as a solid surface or clothing. Surface skin wipe sampling will then be conducted to measure the amount of material that has been transferred to or from the skin surface.

    Surface samples will be collected within an hour of contact or application

Study Arms (1)

Participants for Surface Skin Sampling

EXPERIMENTAL

Adult volunteers with healthy, intact skin will have surface skin wipe samples collected following contact with the approved test substances to measure the quantitative transfer of the test substances to and from the skin surface.

Other: Participants for Surface Skin SamplingOther: Elemental metallic leadOther: Tinopal

Interventions

Skin wipe samples will be collected to quantify the amount of the test substances transferred to and from the surface of the participants' skin.

Also known as: No other names
Participants for Surface Skin Sampling

Consumer product fishing tackle made of elemental lead will be handled by the participants.

Also known as: No other names
Participants for Surface Skin Sampling
TinopalOTHER

Tinopal, a fluorescent tracer, will be handled by the participants.

Also known as: No other names
Participants for Surface Skin Sampling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult volunteers with healthy intact skin.

You may not qualify if:

  • Children will be excluded from the study.
  • Adults with a past history of dermal sensitization, skin allergy, or dermal irritation or dermatitis because of the potential to have compromised barrier function in the skin.
  • Adults who are unwilling to follow protocol requirements.
  • Adults who have a documented history of lead poisoning.
  • Adults who have a concurrent contagious illness or other stressor which in the opinion of the investigator may interfere with the subject's ability to perform the study's requirements.
  • Adults who have open wounds or otherwise compromised skin integrity on their hands.
  • Adults who are pregnant or nursing.
  • Adults who lack the capacity to provide informed voluntary consent to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Interventions

Tinopal

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2015

First Posted

August 20, 2015

Study Start

August 1, 2015

Primary Completion

July 31, 2019

Study Completion

July 31, 2019

Last Updated

August 15, 2019

Record last verified: 2019-08

Locations